{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:03:23Z","timestamp":1790215403050,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jconrel.2026.115220","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:19:39Z","timestamp":1785453579000},"page":"115220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Injectable and sprayable supramolecular prodrug hydrogel for long-acting chemo-hormonal therapy of prostate cancer"],"prefix":"10.1016","volume":"398","author":[{"given":"Qi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feihu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115220_bb0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024, CA","volume":"74","author":"Siegel","year":"2024","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2026.115220_bb0010","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s11912-024-01614-6","article-title":"Prostate cancer, pathophysiology and recent developments in management: a narrative review","volume":"26","author":"Almeeri","year":"2024","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.jconrel.2026.115220_bb0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41585-018-0119-5","article-title":"Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies","volume":"16","author":"van der Toom","year":"2019","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.jconrel.2026.115220_bb0020","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.eururo.2018.10.011","article-title":"Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review","volume":"75","author":"Van den Broeck","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jconrel.2026.115220_bb0025","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1470-2045(03)01282-8","article-title":"Excisional surgery for cancer cure: therapy at a cost","volume":"4","author":"Coffey","year":"2003","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2026.115220_bb0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00109-015-1353-4","article-title":"The biology and clinical implications of prostate cancer dormancy and metastasis","volume":"94","author":"Morrissey","year":"2016","journal-title":"J. Mol. Med. (Berlin, Germany)"},{"key":"10.1016\/j.jconrel.2026.115220_bb0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2025.3746","article-title":"Prostate-specific membrane antigen PET-guided intensification of salvage radiotherapy after radical prostatectomy: a phase 2 randomized clinical trial","author":"Belliveau","year":"2025","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.jconrel.2026.115220_bb0040","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.eururo.2024.11.011","article-title":"Novel methods to assess tumor burden and minimal residual disease in genitourinary cancers","volume":"87","author":"Barata","year":"2025","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jconrel.2026.115220_bb0045","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2967\/jnumed.120.252528","article-title":"Biochemical persistence of prostate-specific antigen after robot-assisted laparoscopic radical prostatectomy: tumor localizations using PSMA PET\/CT imaging","volume":"62","author":"Meijer","year":"2021","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2026.115220_bb0050","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/JU.0000000000003892","article-title":"Salvage therapy for prostate cancer: AUA\/ASTRO\/SUO guideline part I: introduction and treatment decision-making at the time of suspected biochemical recurrence after radical prostatectomy","volume":"211","author":"Morgan","year":"2024","journal-title":"J. Urol."},{"key":"10.1016\/j.jconrel.2026.115220_bb0055","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41391-023-00712-z","article-title":"Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification","volume":"27","author":"Shore","year":"2024","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.jconrel.2026.115220_bb0060","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","article-title":"Adverse effects of androgen deprivation therapy and strategies to mitigate them","volume":"67","author":"Nguyen","year":"2015","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jconrel.2026.115220_bb0065","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s41391-021-00323-6","article-title":"Long-term biopsy outcomes in prostate cancer patients treated with external beam radiotherapy: a systematic review and meta-analysis","volume":"24","author":"Singh","year":"2021","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.jconrel.2026.115220_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/aps.2014.18","article-title":"Androgen receptor: structure, role in prostate cancer and drug discovery","volume":"36","author":"Tan","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2026.115220_bb0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jconrel.2021.01.010","article-title":"Targeting therapy for prostate cancer by pharmaceutical and clinical pharmaceutical strategies","volume":"333","author":"Sun","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115220_bb0080","article-title":"DARolutamide ObservationaL (DAROL) study in patients with nonmetastatic castration-resistant prostate cancer: prespecified third interim analysis","author":"Yu","year":"2025","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.jconrel.2026.115220_bb0085","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41391-021-00395-4","article-title":"Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis","volume":"25","author":"Wenzel","year":"2022","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.jconrel.2026.115220_bb0090","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1056\/NEJMoa1800536","article-title":"Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer","volume":"378","author":"Hussain","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.115220_bb0095","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1056\/NEJMoa1815671","article-title":"Darolutamide in nonmetastatic, castration-resistant prostate cancer","volume":"380","author":"Fizazi","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.115220_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100742","article-title":"Taxanes in cancer treatment: activity, chemoresistance and its overcoming","volume":"54","author":"Mosca","year":"2021","journal-title":"Drug Resist."},{"key":"10.1016\/j.jconrel.2026.115220_bb0105","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jconrel.2022.01.010","article-title":"Emerging nanomedicines of paclitaxel for cancer treatment","volume":"342","author":"Chen","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115220_bb0110","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2017.09.026","article-title":"Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy","volume":"267","author":"Wang","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115220_bb0115","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1158\/1535-7163.MCT-23-0420","article-title":"Darolutamide added to docetaxel augments antitumor effect in models of prostate cancer through cell cycle arrest at the G1-S transition","volume":"23","author":"Buck","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2026.115220_bb0120","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1200\/JCO.23.00041","article-title":"Darolutamide plus androgen-deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer by disease volume and risk subgroups in the phase III ARASENS trial","volume":"41","author":"Hussain","year":"2023","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115220_bb0125","article-title":"Self-assembling paclitaxel-mediated stimulation of tumor-associated macrophages for postoperative treatment of glioblastoma","volume":"120","author":"Wang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115220_bb0130","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jconrel.2022.09.001","article-title":"Self-assembly hydrogels of therapeutic agents for local drug delivery","volume":"350","author":"Zheng","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115220_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2025.01.088","article-title":"Self-assembling chemodrug fiber-hydrogel for transarterial chemoembolization and radiotherapy-enhanced antitumor immunity","volume":"380","author":"Peng","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115220_bb0140","article-title":"Supramolecular prodrug hydrogelator as an immune booster for checkpoint blocker-based immunotherapy","volume":"6","author":"Wang","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115220_bb0145","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.apsb.2023.12.008","article-title":"Nano-formulated delivery of active ingredients from traditional Chinese herbal medicines for cancer immunotherapy","volume":"14","author":"Shang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115220_bb0150","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.addr.2016.06.015","article-title":"Peptide-drug conjugates as effective prodrug strategies for targeted delivery","volume":"110\u2013111","author":"Wang","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115220_bb0155","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2024.2400476","article-title":"Recent advances of injectable in situ-forming hydrogels for preventing postoperative tumor recurrence","volume":"31","author":"Wang","year":"2024","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.115220_bb0160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41565-018-0319-4","article-title":"In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment","volume":"14","author":"Chen","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115220_bb0165","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jconrel.2020.01.003","article-title":"Self-assembling and self-formulating prodrug hydrogelator extends survival in a glioblastoma resection and recurrence model","volume":"319","author":"Schiapparelli","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115220_bb0170","doi-asserted-by":"crossref","first-page":"10083","DOI":"10.1021\/acsnano.0c03286","article-title":"Supramolecular tubustecan hydrogel as chemotherapeutic carrier to improve tumor penetration and local treatment efficacy","volume":"14","author":"Wang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115220_bb0175","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1002\/anie.201913087","article-title":"Supramolecular design of unsymmetric reverse bolaamphiphiles for cell-sensitive hydrogel degradation and drug release","volume":"59","author":"Chakroun","year":"2020","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2026.115220_bb0180","doi-asserted-by":"crossref","first-page":"7780","DOI":"10.1021\/acsnano.9b01689","article-title":"Fine-tuning the linear release rate of paclitaxel-bearing supramolecular filament hydrogels through molecular engineering","volume":"13","author":"Chakroun","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115220_bb0185","article-title":"Rapidly gelling sprayable hydrogels integrating carbon quantum dots and plant extracellular vesicles enable multifunctional wound care via photothermal management, immunomodulation, and ferroptosis","volume":"21","author":"Ding","year":"2025","journal-title":"Small Weinh. Bergstr. Ger."},{"key":"10.1016\/j.jconrel.2026.115220_bb0190","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1021\/acs.nanolett.2c00967","article-title":"Collagen-binding peptide-enabled supramolecular hydrogel design for improved organ adhesion and sprayable therapeutic delivery","volume":"22","author":"Anderson","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115220_bb0195","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1096\/fj.13-235440","article-title":"Unexpected low-dose toxicity of the universal solvent DMSO","volume":"28","author":"Galvao","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2026.115220_bb0200","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.heares.2007.12.002","article-title":"Cytotoxic effects of dimethyl sulphoxide (DMSO) on cochlear organotypic cultures","volume":"236","author":"Qi","year":"2008","journal-title":"Hear. Res."},{"key":"10.1016\/j.jconrel.2026.115220_bb0205","doi-asserted-by":"crossref","first-page":"D672","DOI":"10.1093\/nar\/gkae909","article-title":"KEGG: biological systems database as a model of the real world","volume":"53","author":"Kanehisa","year":"2025","journal-title":"Nucleic Acids Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926006243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926006243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:00:25Z","timestamp":1790211625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926006243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":41,"alternative-id":["S0168365926006243"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115220","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Injectable and sprayable supramolecular prodrug hydrogel for long-acting chemo-hormonal therapy of prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115220","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115220"}}